Skip to content

Clinical trials

Completed Atherosclerosis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Completed Country / region: Netherlands Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20053
20076
20085
20096
20102
20115
20124
20131
20145
20152
20163
20172
20183
20203
20214
20226

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center8
Maastricht University Medical Center7
GlaxoSmithKline5
UMC Utrecht4
AstraZeneca3
Amgen2
Boston Scientific Corporation2
Eli Lilly and Company2
Infraredx2
NewAmsterdam Pharma2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis62
Coronary Artery Disease13
Cardiovascular Diseases12
Coronary Disease6
Dyslipidemias6
Hypercholesterolemia6
Hyperlipidemias5
Myocardial Infarction5
Acute Coronary Syndrome4
Peripheral Arterial Disease4

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.